Figure 3.

Association between tumor angiogenesis score and survival of breast cancer patients. Progression-free survival (PFS), Disease-Free (DFS), Disease-Specific (DSS), and Overall Survival (OS) of angiogenesis score low (blue) and high (red) in Whole breast cancer cohort, and each subtypes; estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-), triple negative breast cancer (TNBC), and HER2-positive, in the TCGA cohorts. The median was used as cut-off to divide into high and low score groups within each cohort. Log rank test was used to compare between two groups with Kaplan–Meier survival curves and to calculate p values.